explore -WSS

explore

author：focus 2025-09-14 21:55:12 - browse：9187

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： What to make of Biden’s latest efforts on cancer research

WSS

A virus, fished out of a lake, may have saved a man’s life

Chemotherapy drug shortage eases slightly but still widespread

Long Covid needs a new name — and a new frame

FDA proposes changes to key medical devices approval pathway

VC firm General Catalyst wants to buy a health system

Food makers to regulators: Ultra

explore

explore

focus

Medicare proposal to cover medical devices draws a mixed reaction

How housing is health care on Long Island

Medicare proposal to cover medical devices draws a mixed reaction

FDA approves updated Covid vaccines

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Colorectal cancer study finds potential in overlooked immune cell

As demand for Covid shots wanes, Moderna seeks its next success

Hospitals consider fixing cancer drug shortages on their own

Moonlake's readout produced a cash windfall. Risks remain

VC firm General Catalyst wants to buy a health system

explore

Physician executives need more than on

Phenylephrine and the overlooked value of the placebo effect

Colorectal cancer study finds potential in overlooked immune cell

New Covid vaccine is recommended for everyone 6 months or older

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Diverse clinical trials: Why aren’t we there yet?

hotspot

focus

Wikipedia

leisure time